Society News Now

BOC, ASCLS, and ASCP Meet with CMS on Nursing Degree Equivalency Rule

The ASCP Board of Certification (BOC), American Society for Clinical Laboratory Science (ASCLS) and American Society for Clinical Pathology (ASCP) met on Sept. 27 with the Centers for Medicare and Medicaid Services (CMS) in opposition to the Agency's April 1st declaration that a degree in nursing is equivalent to a degree in the biological sciences.

The groups representatives presented CMS with a petition, signed by more than 35,000 individuals opposed to CMS's degree equivalency policy. The petition drive was a community-wide effort led by ASCP and ASCLS to raise concern about CMS's policy that the nursing degree is equivalent to a biological sciences degree for purposes of doing non-waived laboratory testing under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.

The Agency's action, outlined in an April 1 memo, could allow an individual with a bachelor's degree in nursing to perform high complexity testing. Per the CLIA regulations, individuals with a bachelor's degree in a chemical, physical, or biological science are not required to complete training prior to performing high complexity laboratory testing. The April memorandum provided no reasoning behind the decision.

During the meeting, agency officials stated that the memorandum reflected a long standing "internal policy" that had been developed to address concerns about a shortage of testing personnel at physician office laboratories in rural areas. These testing sites are not often staffed by qualified laboratory professionals, such as those individuals who may be certified by the BOC. In response, representatives from ASCP, ASCLS, and the BOC raised concerns about negative impacts on patient care and the need to ensure the accuracy and reliability of all laboratory test results.

In addition, laboratory representatives provided CMS with side-by-side comparisons of typical nursing degree programs and laboratory science programs, noting that nursing degrees fall far short of the scientific coursework required to earn a degree in the biological sciences. In its June 22 letter to CMS, the BOC Board of Governors articulated concerns that nursing degrees provide only a fraction of the scientific coursework required for a biological sciences degree and that what scientific coursework nursing programs do require does not approach the level of achievement involved in obtaining a biological sciences degree.

During the meeting, representatives cited comments received from their respective memberships, including those from several individuals who hold degrees in both nursing and the biological sciences that agreed that the nursing degree does not provide the scientific foundations necessary to perform non-waived laboratory testing reliably.

The Agency indicated that it understood and appreciated our concerns. Agency representatives also indicated that CMS will be working to address this issue, and that it is currently examining how best to implement a change in policy. CMS noted that fixing this issue may require the Agency to propose new regulations and that if such a change is required it will soon begin working on draft regulations.

ASCLS appreciates its invaluable, federated partnership with ASCP through the BOC that has allowed the laboratory community to speak with one voice. Together, we will be working with CMS to develop a solution and hope to report progress on newsworthy developments soon.

Attending the meeting were ASCLS Executive Vice President Jim Flanigan, CAE; ASCLS Executive Vice President Emeritus Elissa Passiment, EdM; ASCP Chief Executive Officer E. Blair Holladay, PhD, SCT(ASCP)CM; BOC Executive Director Pat Tanabe, MPA, MLS(ASCP)CM; ASCP Chief Officer for Science, Technology and Policy Jeff Jacobs, MA; and ASCP Director for the Center for Public Policy Matthew Schulze.

To share your thoughts, visit the ASCLS Open Community or our Facebook page.

Share Your Advancements That Bring Efficiency to the Clinical Laboratory

ASCLS is participating with the Clinical Laboratory Management Association (CLMA) on its Increasing Clinical Effectiveness™ (ICE) program designed to demonstrate positive contributions to the laboratory through increasing efficiency and value. Each year, CLMA collects abstracts that demonstrate these innovations and shares them with the laboratory community.

Health care is in the midst of unprecedented change, as it moves from a fee-for-service model to one that reimburses for value. This “volume to value” shift requires laboratories to re-think their approach to meeting the needs of their institutions or their agencies. This shift will require laboratories to broaden their focus beyond cost savings and operational efficiency to include measurable positive impact on patient outcomes.

Participate in ICE by submitting an abstract describing testing-related interventions and the quantifiable positive impact for patients produced. Winners will be recognized at CLMA's annual KnowledgeLab, March 26-29, 2017 in Nashville, Tenn. The highest rated abstract will also have the opportunity to present at the IFCC EuropMedLab 2017 in Athens, Greece, with paid airfare and registration.

Abstract submissions are due Friday, September 30. Abstracts should be 750 words or less across all four sections:

  • Statement of Problem or Background
  • Intervention/Study
  • Plan/Measures Data Analysis and Results
  • Discussion and Lessons Learned

If you have made important advancements to efficiency in the clinical laboratory field receive recognition for your contributions by submitting an abstract, sharing the results of your efforts and helping your peers learn from your experience.

Resources
Frequently Asked Questions
Library of Previous ICE Submissions
Program Requirements and Guidelines

Why do we need the ICE initiative?
In the USA, a shift in reimbursement is occurring from fee-for-service to value-based. Since the clinical laboratory represents only 3-5% of the national health expenditure, value cannot be impacted by focusing only on reducing laboratory costs. Therefore, it is imperative we shift our focus to clinical effectiveness to address the larger opportunity of waste that the IOM estimates at 30% of health expenditures.

What kinds of projects would meet the published criteria?
There are many kinds of projects that could meet the criteria. The current focus on reducing unnecessary repeat testing is an example if it can be clearly shown it is unnecessary and not just a means to save money. Data mining efforts that reduce the absence of follow-up testing associated with abnormal results is another example. Projects that increase the screening of appropriate adults for diabetes could be another. In each case, the key will be identifying appropriate outcome measures.

{/textblock_content}[/yee_text_block][/yee_column][/yee_row]

Clinical Laboratory Science Editor-in-Chief

Applications for editor-in-chief (EIC) for Clinical Laboratory Science are now being accepted.

The EIC provides leadership and direction that results in the publishing of a well-respected, peer-reviewed, scientific journal. The EIC develops and reviews manuscripts, organizes journal functions to maintain editorial integrity and evaluates and makes adjustments to the journal as appropriate. Applicants should be a member of ASCLS, have authored peer reviewed publications, and served as a section editor of the journal or a similar position with another journal.

Clinical Laboratory Science is the official journal of the American Society for Clinical Laboratory Science (ASCLS).

Interested applicants should review the complete job description.

The journal is published quarterly by Westminster Publishers and is listed in PubMed. Application can be made vie email by September 1, 2016 to ASCLS President-Elect Suzanne Campbell (suzanne.campbell@hotmail.com).

Society News Now, Special Edition, February 9, 2016

 
SNN Header

SPECIAL EDITION  February 9, 2016

NEW EXECUTIVE VICE PRESIDENT

The Board of Directors of the American Society for Clinical Laboratory Science (ASCLS) is pleased to announce the selection of James Flanigan as ASCLS Executive Vice President to succeed Elissa Passiment, who announced her pending retirement earlier last year.

James “Jim” Flanigan, CAE comes to ASCLS from the Society of Critical Care Medicine, where he was the Director of Marketing.  He is the chief revenue officer responsible for generating nearly 80% of the Society’s gross income through program and product marketing and membership programs as well as institutional and international sales and industry relations. 

Prior to joining the SCCM staff, Jim served as Director of Marketing for the American Veterinary Medical Association where he oversaw the association’s member, market and economic research as well as the AVMA’s public education campaigns and association-wide branding.  He is a 26 year veteran of the association management profession and a graduate of Iowa State University with a degree in Journalism and Mass Communications.

He received his Certified Association Executive (CAE) credential in 2013. 

Jim and his wife Kris have two sons.  He and his family, which includes two cats, live in Carol Stream, Illinois, a western suburb of Chicago.

Jim will be joining ASCLS March 1, 2016.  Elissa will team with Jim for a yet-to-be-determined period of transition.

The Board of Directors would like to thank the EVP Search Committee for their dedication during the search process.

Of course, the Board would also like to acknowledge Elissa’s dedication during her almost 21 years of service to ASCLS as our EVP and for her prior service as a Past President and member.  Elissa stated that she is looking forward to attending a national meeting with husband Joe and having time to socialize!

Barbara Snyderman

President

Dr. Tim Randolph receives the Alumni Humanitarian Award from the University of Illinois Springfield

 

Tim Randolph UIS 2015 Humanitarian

The University of Illinois Springfield honored the significant contributions of Dr. Tim Randolph during the university’s annual Alumni Gala on Friday, November 6, 2015 at the Abraham Lincoln Presidential Museum.

Dr. Randolph was honored with the Alumni Humanitarian Award for significant contributions of leadership or service to improve the lives of others and the welfare of humanity.

Dr. Randolph received a bachelor’s degree in medical technology 1983. He is a tenured associate professor and chairman of the department of Biomedical Laboratory Science, Doisy College of Health Sciences, at Saint Louis University Health Sciences Center. He is also founder and President of Randolph World Ministries, Inc., a medical mission ministry that establishes and develops medical services in existing clinics in Haiti.

Randolph World Ministries provides a full range of medical services to over 20 Haitian clinics by offering training, materials, consultation, and personal visits to each facility; conducting mobile clinics in remote areas of Haiti where healthcare is unavailable; developing and implementing small business start-up companies to elevate individual families and grow a local economy; providing emergency relief following natural disasters and other types of urgent needs.

Prior to his work with Randolph World Ministries, Dr. Randolph was employed as a medical technologist at Memorial Medical Center in Springfield. While earning his doctorate degree from Warnborough University, he developed a new diagnostic test for sickle cell anemia to be used in developing countries – a test which earned a U.S. patent.